Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

8,441 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,766
Recruiting: 1,006
Ph III recruiting: 98
Growth YoY: −4.7%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 35.7%
Trials / 1,000 deaths: 74.9 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,353)

clinicaltrialsPublishedShowing 7,801–7,850 of 8,441 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01659047	A Phase 2, Single-Arm, Open-Label Study Evaluating the Efficacy and Safety of Single Agent GS 1101 (CAL 101) as Therapy for Previously Treated Chronic Lymphocytic Leukemia	withdrawn	Phase 2	0	Gilead SciencesINDUSTRY	0	Sep 7, 2012	clinicaltrials
NCT00666211	Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain	completed	Phase 3	98	Vanderbilt-Ingram Cancer CenterOTHER	1	Sep 6, 2012	clinicaltrials